ConductScience.org, home

Paper32059697

Better influenza vaccines: an industry perspective.

Chen JR and 3 others. J Biomed Sci, 2020. Cited by 107 papers, by iCite.

Cite this record

ConductScience Library. Better influenza vaccines: an industry perspective. Papers, record 32059697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32059697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Better influenza vaccines: an industry perspective.
PubMed
Journal
J Biomed Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
107
iCite
Relative citation ratio, by iCite
5.09
iCite
Revised in PubMed
2021-01-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen JRJuine-Ruey
2Liu YMYo-Min
3Tseng YCYung-Chieh
4Ma CChehttps://orcid.org/0000-0002-4741-2307

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycoproteinsMajor topic
Immunogenicity, VaccineMajor topic
Influenza VaccinesMajor topic
Protein EngineeringMajor topic
Viral ProteinsMajor topic
Glycosylation
Humans

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AS-SUMMIT-108Academic Sinica Genomics Research Center Summit ProjectPubMed

Source PubMed

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17966893The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial.JAMA1994https://conductscience.org/library/papers/7966893PubMed
229643370How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin.Nat Commun2018https://conductscience.org/library/papers/29643370PubMed
319465683Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.Science2009https://conductscience.org/library/papers/19465683PubMed
426439108A review of the changes to the licensing of influenza vaccines in Europe.Influenza Other Respir Viruses2016https://conductscience.org/library/papers/26439108PubMed
526119736Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.Cell Rep2015https://conductscience.org/library/papers/26119736PubMed
69060710Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.J Virol1997https://conductscience.org/library/papers/9060710PubMed
729506129A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.J Infect Dis2018https://conductscience.org/library/papers/29506129PubMed
824595369Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family.mBio2014https://conductscience.org/library/papers/24595369PubMed
912660783Ecological and immunological determinants of influenza evolution.Nature2003https://conductscience.org/library/papers/12660783PubMed
103016304Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.J Virol1986https://conductscience.org/library/papers/3016304PubMed
114717617Control of influenza.Med J Aust1973https://conductscience.org/library/papers/4717617PubMed
1228636855Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.N Engl J Med2017https://conductscience.org/library/papers/28636855PubMed
1329479277Intranasal influenza vaccine: Why does Canada have different recommendations from the USA on its use?Paediatr Child Health2018https://conductscience.org/library/papers/29479277PubMed
1429100705Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.Vaccine2018https://conductscience.org/library/papers/29100705PubMed
1520878593DNA-based influenza vaccines: evaluating their potential to provide universal protection.IDrugs2010https://conductscience.org/library/papers/20878593PubMed
1621846636Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.J Infect Dis2011https://conductscience.org/library/papers/21846636PubMed
1721506635ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.Expert Rev Vaccines2011https://conductscience.org/library/papers/21506635PubMed
1824469815Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24469815PubMed
1930782805Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30782805PubMed
2022286307Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.Nat Med2012https://conductscience.org/library/papers/22286307PubMed

See all 91 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 107 citations.

PMIDTitleJournalYearIn PapersSource
42295617mRNA Vaccines for Influenza: Hope for a Universal Vaccine?BioDrugs2026https://conductscience.org/library/papers/42295617PubMed
42198750Hypoxia-Enhanced N110 Glycosylation of Hemagglutinin Promotes H3N2 Influenza Virus Fitness by Modulating Receptor Binding and Immune Evasion.Viruses2026https://conductscience.org/library/papers/42198750PubMed
42081324Enhanced immunogenicity and dose-sparing efficacy of self-amplifying RNA vaccines against seasonal influenza across subtypes.Emerg Microbes Infect2026https://conductscience.org/library/papers/42081324PubMed
41917410The Biological Role of Enveloped Virus Glycosylation and Its Interactions with Antiviral Lectins.Adv Exp Med Biol2026https://conductscience.org/library/papers/41917410PubMed
41795070Genomic surveillance of H1N1, H3N2 and influenza B Victoria lineage viruses in Qingyang (2020-2023): phylogenetic and molecular characteristics analysis of HA/NA genes.BMC Infect Dis2026https://conductscience.org/library/papers/41795070PubMed
41712567Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets.PLoS One2026https://conductscience.org/library/papers/41712567PubMed
41618423The nanoemulsion adjuvant provides antigen dose-sparing effects and enhances maternal passive immune protection for the cell-cultured quadrivalent influenza virus subunit vaccine.Virol J2026https://conductscience.org/library/papers/41618423PubMed
41600688Molecular Characterization of an H3N2 Canine Influenza Virus Isolated from a Dog in Jiangsu, China, in 2025.Vet Sci2025https://conductscience.org/library/papers/41600688PubMed
41520499Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone.Virology2026https://conductscience.org/library/papers/41520499PubMed
41279549Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals.bioRxiv2025https://conductscience.org/library/papers/41279549PubMed
41235250A DNA vaccine based on hemagglutinin and conserved epitopes of influenza B virus provides cross-lineage protection in mice.Front Immunol2025https://conductscience.org/library/papers/41235250PubMed
41156761Epidemiological Shifts in Respiratory Virus Infections Among Older Adults (≥65 Years) Before and After the COVID-19 Pandemic: An 18-Year Retrospective Study in the Republic of Korea.Microorganisms2025https://conductscience.org/library/papers/41156761PubMed
41082385Beyond alarmism: what Australia's influenza season really tells us about Italy.Pathog Glob Health2026https://conductscience.org/library/papers/41082385PubMed
41042449Superior Effectiveness and Estimated Public Health Impact of Cell- Versus Egg-Based Influenza Vaccines in Children and Adults During the US 2023-2024 Season.Infect Dis Ther2025https://conductscience.org/library/papers/41042449PubMed
40909923Co-injection with inactivated Enterococcus faecium and inactivated H1N1 influenza virus intravenously strengthen the protection of H1N1 influenza virus infections in mice.Front Microbiol2025https://conductscience.org/library/papers/40909923PubMed
40872906Advancing Reversed-Phase Chromatography Analytics of Influenza Vaccines Using Machine Learning Approaches on a Diverse Range of Antigens and Formulations.Vaccines (Basel)2025https://conductscience.org/library/papers/40872906PubMed
40796271Understanding off-target growth defects introduced to influenza A virus by synonymous recoding.RNA2025https://conductscience.org/library/papers/40796271PubMed
40733722Ferritin-Based HA DNA Vaccine Outperforms Conventional Designs in Inducing Protective Immunity Against Seasonal Influenza.Vaccines (Basel)2025https://conductscience.org/library/papers/40733722PubMed
40667976Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virus.J Virol2025https://conductscience.org/library/papers/40667976PubMed
39772044Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza.Vaccines (Basel)2024https://conductscience.org/library/papers/39772044PubMed

See all 77 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HAS13036PubTator's text mininghttps://conductscience.org/library/genes/3036NCBI Gene
MGAT14245PubTator's text mininghttps://conductscience.org/library/genes/4245NCBI Gene
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32059697

GET https://conductscience.org/api/papers/v1/32059697/references?page=2